Introduction About JALRA TRIO FORTE TABLET

JALRA TRIO FORTE TABLET is a combination of Dapagliflozin, metformin, and vildagliptin, which belongs to a group of medicines called Antidiabetic agents. It is used as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus (T2DM). Along with management, follow a regular exercise and diet plan as advised by the doctor to achieve better results.

Dapagliflozin increases urinary glucose excretion and reduces blood glucose levels. Metformin works to control blood sugar by helping insulin, naturally produced by your body, decrease the amount of sugar your liver makes and also decrease the amount of sugar your intestines absorb. Vildagliptin is a potent and selective dipeptidylpeptidase-4 (DPP-4) inhibitor that improves glycemic control. Vildagliptin inhibition of DPP-4 results in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).

JALRA TRIO FORTE TABLET is not recommended if you have type 1 diabetes, diabetic ketoacidosis, acute or chronic metabolic acidosis, a history of lactic acidosis, or severe dehydration. Before taking it, inform your doctor if you are scheduled for surgery, x-ray or scanning procedures, or vitamin B12 or folic acid deficiency. JALRA TRIO FORTE TABLET is not recommended for pregnant and breastfeeding women. The safety and effectiveness of JALRA TRIO FORTE TABLET in children and adolescents have not been established.

When taking JALRA TRIO FORTE TABLET, alcohol consumption is not recommended. The most common side effects of taking JALRA TRIO FORTE TABLET are low sugar levels, painful urination, repetitive urination, inflammation of the penis (in men), and allergic reactions. Contact your doctor if any of the above side effects worsen or persist for a longer duration.

Uses Of JALRA TRIO FORTE TABLET

• It is used as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus (T2DM).

How JALRA TRIO FORTE TABLET Works

JALRA TRIO FORTE TABLET is a combination of dapagliflozin, metformin, and vildagliptin, which helps to lower blood glucose levels. Dapagliflozin works by inhibiting the reabsorption of glucose in the kidneys, causing excess glucose to be excreted through urine. By lowering blood glucose levels, dapagliflozin helps to improve glycemic control in patients with type 2 diabetes. Metformin works to control blood sugar by helping insulin, naturally produced by your body, decrease the amount of sugar your liver makes and also decrease the amount of sugar your intestines absorb. Vildagliptin is a potent and selective dipeptidylpeptidase-4 (DPP-4) inhibitor that improves glycemic control. Vildagliptin inhibition of DPP-4 results in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).

How to use JALRA TRIO FORTE TABLET

Take JALRA TRIO FORTE TABLET as advised by your physician. Swallow JALRA TRIO FORTE TABLET with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending on your age, body weight, and disease condition. Do not stop taking JALRA TRIO FORTE TABLET without informing your doctor. 

Side Effects Of JALRA TRIO FORTE TABLET

How To Manage Side Effects

Hypoglycemia

Eat or drink 15 to 20 grams of fast-acting carbohydrates. These are sugary foods or drinks without protein or fat that are easily converted to sugar in the body. Have a snack or meal.

Warning & Precautions

Pregnancy

Contraindicated

JALRA TRIO FORTE TABLET is not recommended for use by pregnant women. Consult your doctor before taking the medicine.

Breastfeeding

Contraindicated

JALRA TRIO FORTE TABLET is not recommended for breastfeeding women as it may pass through breast milk. Consult your doctor before taking JALRA TRIO FORTE TABLET.

Driving and Using Machines

Use with Caution

Do not drive or use any tools or machines if you feel dizzy after taking JALRA TRIO FORTE TABLET.

Alcohol

Contraindicated

Consumption of alcohol is not recommended while taking JALRA TRIO FORTE TABLET.

Kidney

Consult your doctor

JALRA TRIO FORTE TABLET is not recommended for patients with kidney disease or impairment. It should be used with caution in patients with a history of kidney disease. Consult your doctor before taking JALRA TRIO FORTE TABLET.

Liver

Consult your doctor

JALRA TRIO FORTE TABLET is not recommended for patients with severe liver dysfunction. It should be used with caution in patients with liver disease. Consult your doctor before taking JALRA TRIO FORTE TABLET.

Allergy

Contraindicated

Do not take JALRA TRIO FORTE TABLET if you are allergic (hypersensitive) to Dapagliflozin, Metformin, Vildagliptin, or any other ingredients of this medicine.

Heart Disease

Consult your doctor

JALRA TRIO FORTE TABLET is not recommended for use if you have cardiovascular problems or cardiorespiratory insufficiency. It should be used with caution if you have had a heart attack or stroke. Consult your doctor before taking JALRA TRIO FORTE TABLET.

Use In Pediatrics

Consult your doctor

The safety and effectiveness of JALRA TRIO FORTE TABLET in children and adolescents have not been established. Consult your doctor before taking the medicine.

Use In Geriatrics

Use with Caution

JALRA TRIO FORTE TABLET should be used with caution in elderly patients over 65 years of age. Consult your doctor before taking the medicine.

Interactions

A. Drug-Drug interactions:

Before taking JALRA TRIO FORTE TABLET, inform your doctor if you are taking any of the following medicines:

• Other diabetic medications (Ex. glyburide, insulin, and rosiglitazone)
• Water pills (diuretics) (Ex. furosemide)
• Birth control pills (Ex. ethinyl estradiol)
• Sympathomimetics (Ex. xylometazoline)
• Thyroid medicines (Ex, levothyroxine)
• Corticosteroids (Ex. prednisone)
• Anti-epileptic (Ex. phenytoin)
• Anti-lipemic (Ex. nicotinic acid)
• Anti-tubercular (Ex. isoniazid)
• Cardiovascular agents (Ex. nifedipine, digoxin, procainamide, quinidine, amiloride, and triamterene)
• Antimalarial (Ex. quinine)
• Anti-ulcers (Ex. cimetidine, ranitidine)
• Opioid analgesics (Ex. morphine)
• Antibiotics (Ex. trimethoprim, vancomycin)
• Blood thinners (Ex. warfarin)

Overdosage:

If you or anyone else takes too much of JALRA TRIO FORTE TABLET, contact your doctor immediately or go to the nearest hospital right away. Symptoms of an overdose are muscle pain, mild and transient paraesthesia, fever, edema, and hypoglycemia.

Synopsis

More Information

FAQs About JALRA TRIO FORTE TABLET

Q: What is JALRA TRIO FORTE TABLET used for?

A: It is used as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus (T2DM). Along with management, follow a regular exercise and diet plan as advised by the doctor to achieve better results.

Q: Can I stop taking JALRA TRIO FORTE TABLET without consulting your doctor?

A: No. Do not stop taking JALRA TRIO FORTE TABLET without consulting your doctor because it may lead to unwanted side effects.

Q: Can I consume alcohol while taking JALRA TRIO FORTE TABLET?

A: Consumption of alcohol is not recommended while taking JALRA TRIO FORTE TABLET. Consult your doctor for advice before taking the medicine.

Q: Will taking a higher dose of JALRA TRIO FORTE TABLET be more effective?

A: No, taking a higher dose of JALRA TRIO FORTE TABLET will not be effective. Always take the dose as advised by your physician.

Q: How should I take JALRA TRIO FORTE TABLET?

A: Take JALRA TRIO FORTE TABLET as advised by your physician. Swallow JALRA TRIO FORTE TABLET with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending on your age, body weight, and disease condition. Do not stop taking JALRA TRIO FORTE TABLET without informing your doctor.

Q: What are the common side effects of JALRA TRIO FORTE TABLET?

A: The most common side effects of taking JALRA TRIO FORTE TABLET are low sugar levels, painful urination, repetitive urination, inflammation of the penis (in men), and allergic reactions. Contact your doctor if any of the above side effects worsen or persist for a longer duration.

Q: Can JALRA TRIO FORTE TABLET be used in pregnant women?

A: JALRA TRIO FORTE TABLET is not recommended for pregnant women. Consult your doctor before taking the medicine.

Q: Can JALRA TRIO FORTE TABLET be used for children?

A: The safety and effectiveness of JALRA TRIO FORTE TABLET in children and adolescents have not been established. Consult your doctor before taking the medicine.

Q: Who should not take JALRA TRIO FORTE TABLET?

A: JALRA TRIO FORTE TABLET is not recommended for use if you have Type 1 diabetes, diabetic ketoacidosis, acute or chronic metabolic acidosis, a history of lactic acidosis, severe dehydration, kidney disease or impairment, severe liver dysfunction, cardiovascular problems or cardiorespiratory insufficiency, or if you are allergic to dapagliflozin, metformin, or Vildagliptin. Consult your doctor before taking it.

Q: What precautions must be taken while using JALRA TRIO FORTE TABLET?

A: Before taking JALRA TRIO FORTE TABLET, inform your doctor if you have vitamin B12 or folic acid deficiency, kidney disease, liver disease, heart attack or stroke, or if you are scheduled for surgery, x-ray, or scanning procedures.

References

1. KD Tripathi MD. Hormones and related drugs. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, May 2013. Page – 274.

2. Kumar Gautam, Ratikanta Tripathy, Dayanidhi Meher, and Jyoti Prakash Sahoo. Dapagliflozin Versus Vildagliptin as an Adjuvant to Metformin in Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label Study. April 27th, 2023. [Accessed on 12th July 2024] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224707/

3. Novartis Pharma AG. [Revised in July 2020] [Accessed on 12th July 2024] https://www.novartis.com/sg-en/sites/novartis_sg/files/Galvus-Jul2020.SIN-App051120.pdf

4. Strides Pharma Canada Inc. [Revised in February 2021] [Accessed on 12th July 2024] https://pdf.hres.ca/dpd_pm/00060230.PDF

5. AstraZeneca AB. European Medical Agency (EMA). [Accessed on 12th July 2024] https://www.ema.europa.eu/en/documents/product-information/forxiga-epar-product-information_en.pdf

6. Dapagliflozin, Metformin, and Vildagliptin. Leeford Healthcare Ltd. [Accessed on 12th July 20244] https://www.leeford.in/product/3347/dapaford-10-vdm

Useful Diagnostic Tests

• HbA1C, Also known as Glycated Hemoglobin, Glycosylated Hemoglobin
• Blood Glucose Fasting (FBS)
• Post Prandial Blood Sugar (PPBS)
• Insulin-Fasting
• Netmeds Diabetic Checkup
• Advance Diabetes Monitoring (Senior Female)
• Jaanch Diabetic Profile Basic